Sonnet BioTherapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of Warrants Outstanding (Details)

Stockholders' Equity - Schedule of Warrants Outstanding (Details)	3 Months Ended
	Mar. 31, 2018 $ / shares shares
Warrants outstanding, Weighted-average remaining contractual life ( in years)	2 years 2 months 12 days
Warrant [Member]
Number of warrants, outstanding	2,262,615
Warrants outstanding, Weighted-average remaining contractual life ( in years)	1 year 10 months 25 days
Number of warrants exercisable	2,262,615
Range 1 [Member] \| Warrant [Member]
Range of exercise prices, upper limit \| $ / shares	$ 40.00
Number of warrants, outstanding	484,518
Warrants outstanding, Weighted-average remaining contractual life ( in years)	8 months 12 days
Number of warrants exercisable	484,518
Range 2 [Member] \| Warrant [Member]
Range of exercise prices, lower limit \| $ / shares	$ 30.00
Range of exercise prices, upper limit \| $ / shares	$ 39.99
Number of warrants, outstanding	49,990
Warrants outstanding, Weighted-average remaining contractual life ( in years)	1 year 4 months 24 days
Number of warrants exercisable	49,990
Range 3 [Member] \| Warrant [Member]
Range of exercise prices, lower limit \| $ / shares	$ 20.00
Range of exercise prices, upper limit \| $ / shares	$ 29.99
Number of warrants, outstanding	77,950
Warrants outstanding, Weighted-average remaining contractual life ( in years)	1 year 9 months 18 days
Number of warrants exercisable	77,950
Range 4 [Member] \| Warrant [Member]
Range of exercise prices, lower limit \| $ / shares	$ 10.00
Range of exercise prices, upper limit \| $ / shares	$ 19.99
Number of warrants, outstanding	50,300
Warrants outstanding, Weighted-average remaining contractual life ( in years)	3 years
Number of warrants exercisable	50,300
Range 5 [Member] \| Warrant [Member]
Range of exercise prices, lower limit \| $ / shares	$ 0.00
Range of exercise prices, upper limit \| $ / shares	$ 9.99
Number of warrants, outstanding	1,599,857
Warrants outstanding, Weighted-average remaining contractual life ( in years)	8 years 1 month 6 days
Number of warrants exercisable	1,599,857